Arcadia Biosciences, Inc. (RKDA)

Arcadia Biosciences, Inc.'s stock price has declined significantly. A proposed business combination with Roosevelt Resources, LP, was terminated. The company announced its financial results for each quarter of 2024 and 2025. Arcadia Biosciences announced the sale of 1.67 million shares of common stock and shareholders experienced substantial dilution. The company announced the exercise of preferred investment options, resulting in gross proceeds of approximately $2.1 million. Directors resigned and Mark Kawakami was appointed as Chief Financial Officer.

No specific information regarding demand seasonality for Arcadia Biosciences, Inc.'s products and services was found.

Arcadia Biosciences, Inc. is an agricultural biotechnology company focused on producing and marketing plant-based food and beverage products. The company develops crop improvements, primarily in wheat, to enhance farm economics by improving crop performance and their value as food ingredients. Its major products include GoodWheat™, Zola® coconut water, ProVault topical pain relief, SoulSpring bath and body care, agronomic wheat traits, and HB4 technology in soybeans.

Arcadia Biosciences, Inc. operates in the United States, Argentina, India, and Canada. The company's corporate headquarters are located in Dallas, Texas, with an additional office in Sacramento, California.

Arcadia Biosciences has focused on expanding its product lines, including GoodWheat™ Mac & Cheese, Quikcakes, and Pancake & Waffle Mixes. The significant decline in stock price and substantial shareholder dilution could affect investor confidence and the company's overall reputation among the investment community.

Arcadia Biosciences, Inc. has both institutional and individual owners. Institutional ownership is reported to be around 1.9% to 17.73% of the stock and insider ownership is reported to be around 0.55% to 8.20%. Major institutional shareholders include Vanguard Group Inc, State Street Corp and Geode Capital Management, Llc. Notable individual insiders include Terri C. Bishop, Darby E. Shupp, Uday Garg, and James Richard Reis.